Alvotech Revenue vs. Market Capitalization

ALVO Stock  USD 11.90  0.38  3.09%   
Considering the key profitability indicators obtained from Alvotech's historical financial statements, Alvotech may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Alvotech's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2019-03-31
Previous Quarter
198.8 M
Current Value
102.9 M
Quarterly Volatility
43.2 M
 
Covid
At this time, Alvotech's Price To Sales Ratio is very stable compared to the past year. As of the 24th of February 2025, Sales General And Administrative To Revenue is likely to grow to 1.72, while Days Sales Outstanding is likely to drop 282.00. At this time, Alvotech's Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 24th of February 2025, Interest Income is likely to grow to about 5.8 M, while Net Interest Income is likely to drop (122.9 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Equity0.490.53
Significantly Down
Slightly volatile
For Alvotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Alvotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Alvotech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Alvotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Alvotech over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.70)
Earnings Share
(1.85)
Revenue Per Share
1.557
Quarterly Revenue Growth
4.786
Return On Assets
(0.01)
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Alvotech Market Capitalization vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Alvotech's current stock value. Our valuation model uses many indicators to compare Alvotech value to that of its competitors to determine the firm's financial worth.
JavaScript chart by amCharts 3.21.15MMNFFRDYCTLTALKSITCIPCRXALVO 02B4B6B8B10B12B14B16B 050B100B150B200B250B300B
Alvotech is rated below average in revenue category among its peers. It is rated below average in market capitalization category among its peers creating about  40.55  of Market Capitalization per Revenue. At this time, Alvotech's Total Revenue is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alvotech's earnings, one of the primary drivers of an investment's value.

Alvotech Revenue vs. Competition

Alvotech is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 288.77 Billion. Alvotech adds roughly 91.43 Million in revenue claiming only tiny portion of equities under Health Care industry.
JavaScript chart by amCharts 3.21.15OthersALKSCTLTRDYMMNFFALVO

Alvotech Market Capitalization vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Alvotech

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
91.43 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Alvotech

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
3.71 B
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Alvotech Market Capitalization vs Competition

Alvotech is rated below average in market capitalization category among its peers. Market capitalization of Health Care industry is presently estimated at about 50.95 Billion. Alvotech holds roughly 3.71 Billion in market capitalization claiming about 7% of equities under Health Care industry.
JavaScript chart by amCharts 3.21.15OthersRDYCTLTITCIMMNFFALVO
Capitalization  Valuation  Total debt  Workforce  Revenue

Alvotech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Alvotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Alvotech will eventually generate negative long term returns. The profitability progress is the general direction of Alvotech's change in net profit over the period of time. It can combine multiple indicators of Alvotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income47.6 M50 M
Net Interest Income-117 M-122.9 M
Interest Income5.5 M5.8 M
Operating Income-319.4 M-335.3 M
Net Loss-496.6 M-471.7 M
Income Before Tax-585.9 M-615.2 M
Total Other Income Expense Net-266.6 M-253.2 M
Net Loss-462.2 M-439.1 M
Net Loss-496.6 M-471.7 M
Income Tax Expense-89.4 M-93.9 M
Change To Netincome130.7 M137.2 M
Net Loss(2.79)(2.93)
Income Quality 0.51  0.69 
Net Income Per E B T 0.76  0.65 

Alvotech Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Alvotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Alvotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Alvotech's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Alvotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

Use Investing Themes to Complement your Alvotech position

In addition to having Alvotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities - Regulated Electric Thematic Idea Now

Utilities - Regulated Electric
Utilities - Regulated Electric Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities - Regulated Electric theme has 6 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities - Regulated Electric Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock:
Check out Trending Equities.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
To fully project Alvotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Alvotech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Alvotech's income statement, its balance sheet, and the statement of cash flows.
Potential Alvotech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Alvotech investors may work on each financial statement separately, they are all related. The changes in Alvotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alvotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Trending Assets

CYTH
Cyclo Therapeutics
0.91  -0.04  -4.21 
LFCR
Lifecore Biomedical
5.61  -0.12  -2.09 
COLL
Collegium Pharmaceutical
29.13  -0.62  -2.08 
ALKS
Alkermes Plc
35.32  -0.18  -0.51